Bromide

Bromide

SCHEMBL475865

C=CC(=O)NCCC[N+](C)(C)C.[Br-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 3/20 0.38
ZDHHC20 Q5W0Z9 1/20 0.56
ZDHHC2 Q9UIJ5 1/20 0.56
KMT2A Q03164 3/20 0.46
ATM Q13315 1/20 0.46
TSHR P16473 2/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.41
TGM2 P21980 3/20 0.38
CBLB Q13191 3/20 0.37
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
MEN1 O00255 2/20 0.36
KDM4E B2RXH2 1/20 0.36
APEX1 P27695 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PMP22 Q01453 1/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL192702 0.98 ZDHHC20 (0.58) ZDHHC20ZDHHC2KMT2AATMTSHR
Fluoride Ion SCHEMBL17105892 0.96 ZDHHC20 (0.56) ZDHHC20ZDHHC2KMT2AATMTSHR
Hydrochloric Acid SCHEMBL26669425 0.96 ZDHHC20 (0.56) ZDHHC20ZDHHC2KMT2AATMTSHR
Iodide SCHEMBL17105877 0.96 ZDHHC20 (0.56) ZDHHC20ZDHHC2KMT2AATMTSHR
Iodide SCHEMBL2254575 0.96 ZDHHC20 (0.56) ZDHHC20ZDHHC2KMT2AATMTSHR
Hydrochloric Acid SCHEMBL3405400 0.96 ZDHHC20 (0.56) ZDHHC20ZDHHC2KMT2AATMTSHR
Hydrochloric Acid SCHEMBL127417 0.96 ZDHHC20 (0.56) ZDHHC20ZDHHC2KMT2AATMTSHR
Water SCHEMBL2355003 0.96 ZDHHC20 (0.56) ZDHHC20ZDHHC2KMT2AATMTSHR
Bromide SCHEMBL6116865 0.94 ZDHHC20 (0.59) ZDHHC20ZDHHC2KMT2AATMTSHR
Hydrochloric Acid SCHEMBL31470991 0.94 ZDHHC20 (0.55) ZDHHC20ZDHHC2KMT2AATMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115400601-B Anti-pollution ion exchange membrane and preparation method and application thereof 浙江大学 2025-02-11 CN claimed
WO-2025023759-A1 ANION EXCHANGE MEMBRANE AND METHOD FOR MANUFACTURING SAME 도레이첨단소재 주식회사 2025-01-30 WO claimed
WO-2024254965-A1 POLYELECTROLYTE GEL, PREPARATION METHOD THEREFOR AND USE THEREOF 清华大学 2024-12-19 WO claimed
CN-118871639-A Long-acting washing-resistant antibacterial deodorizing textile and preparation method thereof 水木聚力接枝纺织新技术(深圳)有限公司 2024-10-29 CN claimed
WO-2024131999-A2 LONG-ACTING WASHING-RESISTANT ANTIBACTERIAL DEODORIZING TEXTILE AND PREPARATION METHOD THEREFOR 水木聚力接枝纺织新技术(深圳)有限公司 2024-06-27 WO claimed
CN-117447653-A Cationic cyclodextrin microsphere and preparation method and application thereof 科睿驰(深圳)医疗科技发展有限公司 2024-01-26 CN claimed
CN-111205380-A Preparation method of quaternary ammonium salt type cationic povidone iodine antibacterial material 西北师范大学 2020-05-29 CN claimed
US-7999031-B2 Process for preparing an aqueous dispersion of a quaternary ammonium salt containing vinyl copolymer BOSTIK, INC. (US) 2011-08-16 US claimed
US-20100048801-A1 Process For Preparing an Aqueous Dispersion of a Quaternary Ammonium Salt Containing Vinyl Copolymer BOSTIK, INC. (US) 2010-02-25 US claimed
EP-1937733-B1 PROCESS FOR PREPARING AN AQUEOUS DISPERSION OF A QUATERNARY AMMONIUM SALT CONTAINING VINYL COPOLYMER BOSTIK INC (US) 2009-12-30 EP claimed
EP-1539259-A1 ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME Kimberly-Clark Worldwide, Inc. (US) 2005-06-15 EP claimed
EP-1539880-A1 IMPROVED ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME Kimberly-Clark Worldwide, Inc. (US) 2005-06-15 EP claimed
WO-2004026958-A1 IMPROVED ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME KIMBERLY-CLARK WORLDWIDE, INC. (US) 2004-04-01 WO claimed
WO-2004026352-A1 USE AS BINDER OF ION TRIGGERABLE, VINYL-BASED CATIONIC POLYMERS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2004-04-01 WO claimed
WO-2004026354-A1 ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME KIMBERLY-CLARK WORLDWIDE, INC. (US) 2004-04-01 WO claimed
WO-2004026351-A2 IMPROVED ION TRIGGERABLE, CATIONIC POLYMERS, A METHOD OF MAKING SAME AND ITEMS USING SAME KIMBERLY-CLARK WORLDWIDE, INC. (US) 2004-04-01 WO claimed
US-20040062791-A1 Ion triggerable, cationic polymers, a method of making same and items using same KIMBERLY-CLARK WORLDWIDE, INC. 2004-04-01 US claimed
US-20040063888-A1 Ion triggerable, cationic polymers, a method of making same and items using same KIMBERLY-CLARK WORLDWIDE, INC. 2004-04-01 US claimed
US-20040058606-A1 Ion triggerable, cationic polymers, a method of making same and items using same KIMBERLY-CLARK WORLDWIDE, INC. 2004-03-25 US claimed
US-20040055704-A1 Ion triggerable, cationic polymers, a method of making same and items using same KIMBERLY-CLARK WORLDWIDE, INC. 2004-03-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040062791-A1 Ion triggerable, cationic polymers, a method of making same and items using same PWWP2B, DSG1, WDR1 ACHE 1823/4885ZDHHC20 2226/4885ZDHHC2 3683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.